The Effects of Pyridoxine Supplements on the Dental Caries Experience of Pregnant Women

Abstract

Pyridoxine supplements were given to early prenatal patients, either in a capsule (one 20 mg. capsule daily), or as lozenges (6.67 mg., three times daily). The dental DMF rating was estimated at the beginning of the treatment period, and again, approximately six weeks postpartum. The patients who received the pyridoxine supplement showed, on the average, a smaller increase in DMF rating than a comparison group of antenatal patients observed for the same period. The smallest increment in DMF rating was noted in the gravida receiving pyridoxine in the lozenge form.